• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Dexcom

Dexcom, Retta, Beyond Type 2 team up to raise glucose awareness

September 23, 2024 By Sean Whooley

Dexcom Retta showing Stelo glucose levels (1)

Dexcom (Nasdaq:DXCM) today announced a collaboration to establish National Glucose Awareness Week from Sept. 23-29, 2024. The San Diego-based continuous glucose monitor (CGM) maker aims to close the glucose knowledge gap. In partnership with the nonprofit Beyond Type 2, Dexcom wants to encourage people to take action “to own their glucose health.” According to a […]

Filed Under: Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Beyond Type 2, Dexcom

Dexcom CGM worn in outer space on Polaris Dawn mission

September 10, 2024 By Sean Whooley

Polaris-Dawn (1)

Dexcom (Nasdaq:DXCM) announced today that its G6 CGM is being worn by astronauts as part of the Polaris Dawn mission. Polaris Dawn launched this morning with astronauts wearing the G6 to better understand the effects of spaceflight on human health. The crew intends to conduct research to advance human health on Earth and the understanding […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom

Dexcom launches Stelo over-the-counter CGM

August 26, 2024 By Sean Whooley

Dexcom Stelo worn by pickleball player

Dexcom (Nasdaq:DXCM) announced today that it launched its Stelo over-the-counter (OTC) continuous glucose monitor (CGM) biosensor. The San Diego-based company made Stelo available for purchase — without prescription — at Stelo.com. Dexcom became the first company to receive FDA clearance for an OTC CGM when the FDA cleared Stelo in March. Abbott followed in June […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom

The 9 largest diabetes technology companies in the world

August 21, 2024 By Sean Whooley

9 largest diabetes companies in the world abbott dexcom medtronic insulet

Diabetes technology comes in all shapes and sizes: insulin delivery systems, continuous glucose monitors and more. The companies that develop these technologies come in all shapes and sizes, too. Some focus entirely (or almost entirely) on solutions for people with diabetes. Others are much larger medtech firms that still have sizable business units that focus […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology, Wall Street Beat Tagged With: abbott, Dexcom, embecta, Insulet, Medtronic, Roche Diabetes Care, Senseonics, Tandem Diabetes Care, Ypsomed

Tandem Diabetes Care integrates t:slim X2 with Dexcom CGMs in Canada

July 29, 2024 By Sean Whooley

Tandem Diabetes Care t-slim X2 Dexcom G7

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched its updated t:slim X2 insulin pump software with Dexcom (Nasdaq:DXCM) CGMs in Canada. San Diego-based Tandem now offers the t:slim X2 pump software with the Dexcom G6 and G7 continuous glucose monitors (CGMs). Health Canada authorized the combination, which already exists on the U.S. market, for […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Dexcom, Tandem Diabetes Care

Dexcom stock falls on Q2 results that came up shy of ‘high standards’

July 26, 2024 By Sean Whooley

Dexcom updated Logo

Dexcom (Nasdaq:DXCM) (Nasdaq:DXCM) shares plummeted today on second-quarter results that came in mixed compared to the consensus forecast. Shares of DXCM fell more than 40% to $63.96 apiece in morning trading today. MassDevice‘s MedTech 100 Index was down slightly. The San Diego-based continuous glucose monitor (CGM) maker yesterday evening reported profits of $143.5 million. That […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Dexcom

Report: Dexcom cuts California jobs in manufacturing, R&D shift

June 27, 2024 By Sean Whooley

Dexcom updated Logo

Dexcom (Nasdaq:DXCM) is reportedly relocating manufacturing operations amid a shift that eliminates more than 500 positions in San Diego. The San Diego Union-Tribune reported that the company plans to keep its headquarters in San Diego. However, its decision to move manufacturing to Arizona signals that Dexcom outgrew its facilities in San Diego. The move takes […]

Filed Under: Business/Financial News, Diabetes, Featured, Patient Monitoring, Technology Tagged With: Dexcom

The biggest stories from the American Diabetes Association (ADA) 2024 Scientific Sessions

June 25, 2024 By Sean Whooley

ADA 2024 Product Images Dexcom Abbott Senseonics Ascensia Insulet Tandem Medtronic Sequel

The American Diabetes Association took to Orlando, Florida, the past few days for its 84th Scientific Sessions as optimism grows over diabetes tech. Topics covered included expanding technologies to the type 2 diabetes population (90% of people with diabetes), GLP-1 drugs, automation, broadening user bases and more. The usual big-hitters stepped up to the plate […]

Filed Under: Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Implants, Patient Monitoring, Pharmaceuticals, Technology Tagged With: abbott, Dexcom, embecta, Insulet, mannkind, Medtronic, Senseonics, Sequel Med Tech, Tandem Diabetes Care

Dexcom CEO explains plans for Stelo CGM, G7 and beyond

June 23, 2024 By Sean Whooley

Dexcom Stelo glucose monitor

Dexcom (Nasdaq:DXCM) CEO Kevin Sayer says the prospect of an over-the-counter CGM made him and other company leaders uneasy. When the company first began planning a glucose monitor for the type 2 diabetes population not using insulin, there were questions about reimbursement, the impact of GLP-1 drugs and other causes for concern. “It made us […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: ADA 2024, Dexcom

Insulet fully launches Omnipod 5 with Dexcom G7 in the U.S. along with iPhone app

June 20, 2024 By Sean Whooley

Insulet Omnipod 5 with Dexcom G7

Insulet (Nasdaq:PODD) announced today that it began a full U.S. launch of Omnipod 5 with the Dexcom G7 continuous glucose monitor (CGM). The company also announced a series of launches and updates, including a limited release of the Omnipod 5 App for iPhone. Insulet also made Omnipod 5 available in France and launched the system […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, Dexcom, Insulet

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Interim pages omitted …
  • Page 24
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS